Pharmicell Co., Ltd. (005690.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In KRW
| Market Cap | 872.05B |
| Enterprise Value | 857.78B |
| P/E Ratio | 13.74 |
| PEG Ratio | 0.11 |
| Price/Sales Ratio | 4.71 |
| Price/Book Ratio | 4.46 |
| Enterprise/Revenue | 4.78 |
| Enterprise/EBITDA | 13.83 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.34 |
| Operating Margin | 0.32 |
| Return On Assets | 0.25 |
| Return On Equity | 0.36 |
| Revenue | 114.06B |
| Revenue/Share | 2,265.53 |
| Gross Profit | 50.01B |
| EBITDA | 36.81B |
| Net Income | 40.33B |
| Diluted EPS | 671.97 |
| Total Cash | 65.67B |
| Total Cash/Share | 1,094.42 |
| Total Debt | 25.53B |
| Total Debt/Equity | 0.18 |
| Current Ratio | 7.15 |
| Book Value Per Share | 2,389.28 |
| 52-Week Change | -1.66 |
| 52-Week High | 21,150 |
| 52-Week Low | 8,140 |
| Moving Average 50 Days | 11,869.8 |
| Moving Average 200 Days | 14,977.55 |
| Average Volume | 790,200 |
| Shares Outstanding | 60M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 50 |
| Trailing Annual Dividend Yield | 0.47 |
| Payout Ratio | 0.06 |
| Last Split Factor | 531:500 |
| Last Split Date | April 30, 2012 |